November 24, 2017

Mobidiag partners up in Estonia

Mobidiag wants to "improve the quality and efficiency of healthcare and aid in the combat against spreading and emerging antimicrobial resistances".
Mobidiag wants to "improve the quality and efficiency of healthcare and aid in the combat against spreading and emerging antimicrobial resistances".
Istock.com/poba

Finnish-French biotechnology company Mobidiag has signed a distribution agreement with Interlux, supplier of technologies for medicine, science and biotechnology industry.

Under the agreement, Interlux becomes the exclusive distributor of the Mobidiag’s Amplidiag product line in Estonia, in vitro diagnostic tests and compatible instrument for the detection of gastrointestinal infections. The agreement is effective immediately.

“Thanks to a large distribution network, our Amplidiag product line is now accessible in most Western European countries,” says Miquel Vernet, CCO at Mobidiag. “This new distribution agreement allows us to introduce the Amplidiag product line to the Baltic region starting with Estonia. We are then very happy to start this new partnership with Interlux to support us in this new market.”

Mobidiag specialises in developing and marketing innovative solutions for molecular diagnostics of infectious diseases. Earlier this year, the company has expanded its distribution networks in Israel and several African countries as well as Italy. Mobidiag also heavily invested in its global sales and marketing channels and opened a new office in the UK.

Share: